Online Presentations (1-5 of 5)

1. BME 695L Lecture 16: FDA and EPA Regulatory Issues

   Online Presentations | 02 Dec 2011 | Contributor(s):: James Leary

   See references below for related reading.16.1      Introduction and overview16.1.1    How does the FDA think about nanomedical systems?16.1.2    The 2006 Nanotechnology Task Force16.2      Some...

2. What We Know and Don’t Know About the Toxicity of Nanomaterials: Challenges in Developing Experimental Approaches for Safety Assessment

   Online Presentations | 24 Dec 2010 | Contributor(s):: Peter L Goering

   This seminar will summarize recent research activities at CDRH/FDA and highlight issues en countered in the characterization and biological responses of some prototypic nanomaterials.

3. BME 695N Lecture 21: FDA and EPA Regulatory Issues

   0.0 out of 5 stars 

   Online Presentations | 27 Nov 2007 | Contributor(s):: James Leary

   Outline:Introduction and overview How does the FDA think about nanomedical systems? The 2006 Nanotechnology Task Force Some details of the Nanotechnology Task Force Report General findings of the report Some initial recommendations of the Task Force Where the FDA may need to meet EPA on nanoscale...

4. Nanotechnologies, Science and Society: Promises and Challenges

   5.0 out of 5 stars 

   Online Presentations | 10 May 2007 | Contributor(s):: James Leary

5. Nanotechnology and Occupational Safety and Health: What are the Issues, What do we know, and What is NIOSH Doing

   0.0 out of 5 stars 

   Online Presentations | 21 Nov 2006 | Contributor(s):: Chuck L Geraci

   Nanotechnology and Occupational Safety and Health: What are the Issues, What do we know, and What is NIOSH Doing